AM21-56: COVID-19 Convalescent Plasma: Impact on Donation Safety and Eligibility

Oct 19, 2021

Collection: 2021 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Nancy L. Van Buren, MD, Medical Director, Innovative Blood Resources
• Jed B. Gorlin, MD, MBA, Innovative Blood Resources, division of New York Blood Center
• Dr. Mary Townsend, MD, Medical Director, Vitalant

Tags: donor hemovigilance noninfectious adverse events blood bankblood center donor collection testing processing

AM21-06: Oral Abstract Session -- Blood Donation

Oct 17, 2021

Collection: 2021 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Eric Senaldi, MD, New York Blood Center
• Dawn Ward, Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA
• W. Alton Russell, PhD, Stanford University
• Dr. Ralph R. Vassallo, MD, Executive Vice President, Chief Medical & Scientific Officer, Vitalant Corporate Medical Affairs
• Roberta Bruhn, MS, PhD, Co - Director, Vitalant Research Institute
• Brian Custer, PhD. MPH, Vitalant Research Institute

Tags: donor hemovigilance noninfectious adverse events donor testing blood bankblood center donor collection testing processing

AM20-82: Firearm Injuries in the United States: National Data and Evolution of the Transfusion Management Evidence Base

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Eric A. Gehrie, MD, Medical Director of the Blood Bank, Refractor Health
• Dr. John R. Hess, MD, Division of Transfusion Medicine, University of Washington
• Dr. Ruchika Goel, MD, MPH, Johns Hopkins University School of Medicine

Tags: donor hemovigilance noninfectious adverse events hematopoietic cell therapytransplant evidence based medical practices transfusion medicine clinical practices donor apheresis public health and policy pediatric transfusion clinical medicine trauma and massive transfusion practices

AM20-44: Delivering Next Generation Cell and Gene Therapies: Toward FDA Approval for Early Stage Clinical Trials

Oct 5, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. David H. McKenna, MD, University of Minnesota
• Dr. Adrian Gee, Baylor College of Medicine
• Dr. Linda Kelley, Moffitt Cancer Center

Tags: donor collections donor hemovigilance noninfectious adverse events cellular therapies and immunotherapies immunotherapies includes car t cells regulations regenerative medicine

AM20-23: Does Assessing Vital Signs Contribute to Blood Donation Safety?

Oct 4, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Mindy Goldman, MD, Medical Director, Donor & Clinical Services, Canadian Blood Services
• Prof. David O. Irving, Australian Red Cross Blood Service
• Jed B. Gorlin, MD, MBA, Innovative Blood Resources, division of New York Blood Center

Tags: donor collections donor hemovigilance noninfectious adverse events patient testing instrumentation blood bankblood center donor collection testing processing

AM20-17: Enlightening Studies in Therapeutic Apheresis: What’s Been Done, What's Happening, and What’s to Come!

Oct 3, 2020 ‐ Dec 31, 2022

Collection: 2020 AABB Annual Meeting On-Demand

Type: Session

Speakers:

• Dr. Yanyun Wu, MD, PhD, Chief Medical Officer, University of Miami
• Dr. Zbigniew M. Szczepiorkowski, MD, PhD, Dartmouth-Hitchcock Medical Center
• Dr. Jeffrey L. Winters, MD, Mayo Clinic

Tags: patient blood management donor collections donor hemovigilance noninfectious adverse events quality control evidence based medical practices transfusion medicine clinical practices therapeutic apheresis donor recruitment and retention disorders